产品名称
Goat Anti-Human IgM, μ-Chain Specific Peroxidase Conjugate, liquid, Calbiochem®
biological source
goat
antibody form
affinity isolated antibody
antibody product type
secondary antibodies
clone
polyclonal
form
liquid
contains
0.02% thimerosal as preservative
species reactivity
human
manufacturer/tradename
Calbiochem®
storage condition
do not freeze
dilution
(Enzyme Immunoassay (1:10,000)
Immunoelectrophoresis )
isotype
IgG
shipped in
wet ice
storage temp.
2-8°C
target post-translational modification
unmodified
Quality Level
Application
Enzyme Immunoassay (1:10,000)
Immunoelectrophoresis (see comments)
Immunoelectrophoresis (see comments)
Disclaimer
To comply with ban of sale of mercury-added products required by The Interstate Mercury Education and Reduction Clearinghouse (IMERC), this product is prohibited to be sold in the following US states: Rhode Island and Connecticut.
Toxicity: Standard Handling (A)
General description
Immunoaffinity purified goat polyclonal antibody conjugated to horseradish peroxidase (HRP). Recognizes human IgM µ-chain.
This Goat Anti-Human IgM, µ-Chain Specific Peroxidase Conjugate is validated for use in Enzyme Immunoassay, Immunoelectrophoresis for the detection of Human IgM, µ-Chain Specific.
Other Notes
Monospecific for human IgM µ-chain as determined by immunoelectrophoresis (IEP) against normal human serum. Variables associated with assay conditions will dictate the proper working dilution.
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In 10 mM PBS, 0.5 mM EDTA, 10% mannose, 2% sucrose, 1% BSA, pH 8.0.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
André Santa Cruz et al.
Nature communications, 14(1), 1772-1772 (2023-03-31)
Several millions of individuals are estimated to develop post-acute sequelae SARS-CoV-2 condition (PASC) that persists for months after infection. Here we evaluate the immune response in convalescent individuals with PASC compared to convalescent asymptomatic and uninfected participants, six months following
Francisco J Martinez et al.
NPJ vaccines, 9(1), 10-10 (2024-01-07)
The receptor-binding domain, region II, of the Plasmodium vivax Duffy binding protein (PvDBPII) binds the Duffy antigen on the reticulocyte surface to mediate invasion. A heterologous vaccine challenge trial recently showed that a delayed dosing regimen with recombinant PvDBPII SalI
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持